Thomas J Tull

11PUBLICATIONS

47CO-AUTHORS

AllergyGene and molecular therapyTumour immunologyMedical microbiology not elsewhere classifiedRheumatology and arthritis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|May 08, 2026

HLA genotype, clinical and immunofluorescence findings of 30 patients with type VII collagen antibody positive subepidermal bullous disease.

|Apr 12, 2026

Low dose methotrexate and superpotent topical steroids in the management of bullous pemphigoid.

Lucy Mackie, Thomas J Tull

|Feb 26, 2026

Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: a scoping review.

Lucy Booth, Xinyi Chen, Katie Stoker

|Jan 19, 2026

Treatment with mycophenolate mofetil as an adjuvant therapy post-rituximab does not improve treatment outcomes in pemphigus.

Vishvan Naidu, Ali Yalcinkaya, Kristina Semkova

|May 20, 2025

A current need for the use of improved and standardized outcome measures by clinical studies of pemphigus.

Thomas J Tull, Jane Setterfield

|Mar 06, 2025

Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor Alpha.

Chara Stavraka, Jitesh Chauhan, Silvia Crescioli

Pageof 2

Frequent Collaborators

Sophia N Karagiannis

Jo Spencer

Mats Bemark

Jacqueline H Y Siu

Michael J Pitcher

Rebekah L Velounias

William Guesdon

Krishnaa T Mahbubani

Richard Ellis

Natalie Watson

Frequent Collaborators

Sophia N Karagiannis

Jo Spencer

Mats Bemark

Jacqueline H Y Siu